A2A Pharmaceuticals, Inc. - Insider Non-Derivative Transactions at Biomea Fusion, Inc. (BMEA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 1, 2023, A2A Pharmaceuticals, Inc.'s relationship to Biomea Fusion, Inc. (BMEA) is TenPercentOwner, and currently has 3,500,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BMEA insiders.
Data Source: SEC.
A2A Pharmaceuticals, Inc. - Insider Non-Derivative Transactions of BMEA Common Stock
A2A Pharmaceuticals, Inc. - Insider Non-Derivative Transactions at BMEA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 2, 2023 | Sell -- (Common Stock) | 50000 | 34.56 | 3500000 |
| Jun 1, 2023 | Sell -- (Common Stock) | 75000 | 33.81 | 3550000 |
| May 13, 2023 | Sell -- (Common Stock) | 25000 | 33.84 | 3625000 |
| May 10, 2023 | Sell -- (Common Stock) | 150000 | 34.5 | 3650000 |
| May 9, 2023 | Sell -- (Common Stock) | 100000 | 33.99 | 3800000 |
| Apr 21, 2023 | Sell -- (Common Stock) | 200000 | 29.12 | 3900000 |
| Apr 1, 2023 | Sell -- (Common Stock) | 200000 | 31.25 | 4100000 |